Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03281668
Other study ID # 16-2996
Secondary ID 1R21HD088852-01A
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2017
Est. completion date November 9, 2018

Study information

Verified date January 2019
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The focus of this pilot study is to evaluate the feasibility of utilizing an evidenced-based high intensity interval training program (HIIT) to improve physical function in patients with knee osteoarthritis (OA).


Description:

All participants will be assigned to the single-arm of the study in which all participants will receive 12 weeks of HIIT, delivered twice per week. The primary outcome will examine the feasibility and acceptability of the 12 week HIIT program in patients with knee OA symptoms ranging from mild to severe. The investigators will determine adherence to and tolerability of HIIT, acceptability, and recruitment and retention rates during the 12 week program. Additional outcomes will include physical function, knee OA symptomatic burden (pain), static standing balance, isometric knee extensor and flexor strength, cardiorespiratory fitness, and body composition.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date November 9, 2018
Est. primary completion date November 9, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria:

- between the ages of 40 and 75 years old

- body mass index of 18.5-50 kg/m²

- exhibits symptomatic knee OA, defined as a diagnosis of knee OA, as identified from University of North Carolina electronic medical records, and current knee symptoms in at least one knee, having a minimum score of 6 out of 20 on the Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC) pain subscale.

Exclusion Criteria:

- individuals diagnosed with a cardiovascular condition restricting exercise

- individuals currently meeting Department of Health and Human Services Guidelines for physical activity (= 150 minutes per week

- individuals currently doing HIIT

- individuals currently participating in physical therapy for knee OA

- individuals currently participating in another OA intervention study

- received a corticosteroid or hyaluronic acid intra-articular injection in the knee during the previous 3 weeks or scheduled for during the intervention

- diagnosis of gout in the knee

- diagnosis of rheumatoid arthritis

- diagnosis of fibromyalgia

- other systemic rheumatic disease

- severe dementia or other memory loss

- active diagnosis of psychosis or uncontrolled substance abuse disorder

- hospitalization for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 3 months

- total joint replacement knee surgery, other knee surgery, meniscus tear, or anterior cruciate ligament (ACL) tear in the past 6 months

- on a waiting list for total joint replacement

- severely impaired hearing or speech

- pregnant or planning to become pregnant while enrolled in the study

- inability to speak English

- serious or terminal illness as indicated by referral to hospice or palliative care

- nursing home residence

- inability to ride a stationary bike

- any other health problems that would prohibit safe participation in the study

- EKG results EKG suggesting the individual would not be able to safely participate in this study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
High intensity interval training (HIIT)
Each training session for High Intensity Interval Training will consist of a 3-5 minute warm-up, followed by 10 repetitions of 1-minute bouts at individualized training intensity with 1-minute rest periods.

Locations

Country Name City State
United States University of North Carolina Chapel Hill North Carolina

Sponsors (3)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent of Potential Participants Screened for the Study Who Are Enrolled Number of participants screened and enrolled divided by the total number of participants screened Baseline
Primary Percentage of Enrolled Participants Retained at the End of the Study Number of participants who completed the study (baseline through 12 week assessments) divided by the total number of enrolled participants with baseline assessments Study completion (12 weeks)
Secondary Average Number of Training Sessions Completed Per Week Up to 2 training sessions were possible each week over the 12 week intervention Weekly measures for 12 consecutive weeks
Secondary Total Number of Training Sessions Completed Total number of training sessions completed out of up to 24 sessions (2 per week over 12 weeks) 12 weeks
Secondary Total Number of Training Weeks Completed Total number of training weeks (up to 12 weeks possible) 12 weeks
Secondary Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score From Baseline to 12 Weeks The WOMAC, a measure of lower extremity pain (5 items), stiffness (2 items), and function (17 items), will be used to measure overall symptomatic burden of knee osteoarthritis (OA). Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a total WOMAC score ranging from 0 (no problems) to 96 (extreme problems). A higher score means a worse outcome. Baseline,12 weeks
Secondary Change in WOMAC Pain Subscale From Baseline to 12 Weeks The WOMAC pain subscale contains 5 items about knee pain. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no pain) to 20 (extreme pain). A higher score means more severe pain. Baseline,12 weeks
Secondary Change in WOMAC Function Subscale From Baseline to 12 Weeks The WOMAC function subscale contains 17 items about knee function during daily activities. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no problems with function) to 68 (extreme problems with function). A higher score means worse function. Baseline, 12 weeks
Secondary Change in 20m Fast Paced Walk Test Measure of the ability to walk quickly over short distances. Participants walk at fast pace that is timed over 2 x 10m. Baseline, 12 weeks
Secondary Change in Number of Chair Stand Repetitions Completed Number of chair stand repetitions completed in 30 seconds Baseline, 12 weeks
Secondary Change in Stair Climb Test Time in seconds to ascend and descend a flight of stairs Baseline, 12 weeks
Secondary Change in Timed Up and Go Time in seconds to rise from a chair, walk 3 m, turn, walk back to chair, and sit down Baseline, 12 weeks
Secondary Change in Feet Together Stand Feet together stand for up to 10 seconds without assistive device Baseline, 12 weeks
Secondary Change in Semi-tandem Stand Heel of one foot placed to the side of the big toe of the other foot, for up to 10 seconds Baseline, 12 weeks
Secondary Change in Tandem Stand One foot in front of the other, heel touching toe, for up to 10 seconds Baseline, 12 weeks
Secondary Change in One Leg Stand One leg stand for up to 30 seconds Baseline, 12 weeks
Secondary Change in Cardiorespiratory Fitness Measure by peak oxygen consumption (VO2peak),to identify fitness level and evaluate cardiovascular effects. Test will establish individual training intensity. Baseline, 12 weeks
Secondary Change in Whole Body Fat Mass fat mass in kilograms, measured with dual energy x-ray absorptiometry (DXA) Baseline, 12 weeks
Secondary Change in Lean Body Mass lean body mass in kilograms, measured with DXA Baseline, 12 weeks
Secondary Change in Visceral Fat visceral fat in kilograms, measured with DXA Baseline, 12 weeks
Secondary Change in Knee Strength Humac isokinetic dynamometer to measure isokinetic power and isometric strength of knee flexors extensors Baseline, 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04651673 - Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
Completed NCT05677399 - Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise. N/A
Active, not recruiting NCT04043819 - Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis Phase 1
Recruiting NCT06000410 - A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee Phase 3
Completed NCT05014542 - Needling Techniques for Knee Osteoarthritis N/A
Recruiting NCT05892133 - Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty N/A
Recruiting NCT05528965 - Parallel Versus Perpendicular Technique for Genicular Radiofrequency N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Active, not recruiting NCT02003976 - A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone N/A
Active, not recruiting NCT04017533 - Stability of Uncemented Medially Stabilized TKA N/A
Completed NCT04779164 - The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis N/A
Recruiting NCT04006314 - Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis N/A
Recruiting NCT05423587 - Genicular Artery Embolisation for Knee Osteoarthritis II N/A
Enrolling by invitation NCT04145401 - Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
Active, not recruiting NCT03781843 - Effects of Genicular Nerve Block in Knee Osteoarthritis N/A
Completed NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05324163 - Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis Phase 3
Completed NCT05529914 - Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis N/A
Recruiting NCT05693493 - Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA? N/A
Not yet recruiting NCT05510648 - Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis N/A